Panalgo Revolutionizes Real-World Data with Launch of LinQ Notes and Ella AI

Boston, MA – May 14, 2025 – Panalgo, a Norstella company dedicated to revolutionizing healthcare analytics, today announced the launch of two game-changing solutions: LinQNotes and Ella AI. Together, these solutions mark a bold step forward in Panalgo’s mission to make insights more accessible, actionable, and immediate. Ella AI and LinQNotes combine the power of structured and unstructured data analysis to deliver a more complete view of the patient journey—from rapid cohort creation to rich clinical context.
Norstella Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2025

New York – March 18, 2025 – Norstella, a leading global provider of pharma intelligence solutions, is proud to have been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2025. This year’s list shines a spotlight on businesses that are shaping industry and culture through their innovations to set new standards and achieve remarkable milestones in all sectors of the economy.
Neelesh Sali Named Managing Director & Country Head of Norstella India

New York – February 5, 2025 – Norstella, a leading global provider of pharma intelligence solutions, is proud to announce the appointment of Neelesh Sali as Managing Director and Country Head for India. With over 30 years of leadership experience driving operational excellence and scaling global organizations, Neelesh brings a proven track record of transformative growth and innovation to Norstella’s mission of smoothing the path to life-saving treatments.
NorstellaLinQ Data Source Added to Atropos Evidence™ Network, Scoring in the Top Decile for Data Quality on Real World Fitness Score®

Palo Alto, CA – February 4, 2025 – Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence (RWE) for care, announces the availability of an initial dataset from NorstellaLinQ on the Atropos Evidence Network. NorstellaLinQ, built by Norstella, one of the largest global pharma intelligence solution providers, is the first and only fully integrated data asset combining real-world data (RWD) and proprietary intelligence from the most trusted brands in the industry, paving the way for breakthroughs in drug development and commercialization.
Norstella Introduces NorstellaLinQ, the Biopharma Industry’s First Fully Integrated Data Asset

NEW YORK – October 8, 2024 – Today, Norstella unveiled NorstellaLinQ, the biopharma industry’s first and only fully integrated data asset combining both real-world data (RWD) — including open and closed claims, lab results and structured and unstructured electronic medical records (EMR) — with Norstella’s proprietary forecasting, clinical, regulatory, payer, coverage and commercial intelligence data.
Panalgo Introduces IHD Cloud, a Transformative Solution for RWE Data and Analytics Centralization

Boston, MA – Sept. 5, 2024 – Panalgo, a Norstella company committed to revolutionizing healthcare data analytics, is announcing the launch of IHD Cloud, a cutting-edge solution that will transform how organizations manage and use real-world data (RWD) to generate real-world evidence (RWE). Powered by Amazon Web Services (AWS), IHD Cloud offers a scalable and flexible platform to centralize data and technology, driving meaningful and timely insights for any evidence generating organization.
In a First for Pharma, Citeline SmartSolutions Take AI to New Levels, Optimizing Clinical Trial Planning and Site Selection

NEW YORK – Aug. 13, 2024 – Citeline, a leader in intelligence solutions for the life sciences industry, has launched two new products — Protocol SmartDesign and Investigator SmartSelect — in its Citeline SmartSolutions suite accelerating the path from pipeline to patient. Citeline SmartSolutions, an industry first, enables users to design and conduct more predictable trials by connecting the robust data assets already trusted by over 3,000 Citeline customers.
Atropos Health Partners with Norstella to Expand the Atropos Evidence™ Network and Structured Clinical Trial Intelligence

BOSTON – June 17, 2024 – Norstella, one of the largest global pharma intelligence solution providers, today announced a strategic partnership with Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care. This collaboration follows Atropos Health’s recent announcement of $33 million in Series B funding, furthering its expansion into life sciences.
Evaluate, a Norstella Company, Announces Acquisition of J+D Forecasting

January 8, 2024, London, UK and Boston, MA – Evaluate, a Norstella company, announced today the acquisition of J+D Forecasting, a leading provider of forecasting solutions for the pharmaceutical industry.
MMIT Wins Titan Health Award for Healthcare Innovation

December 4, 2023, Yardley, PA – MMIT, a Norstella company and the trusted go-to-market partner for overcoming barriers to patient access, is excited to announce that its Patient Access Analytics solution has won a Titan Health Award, which celebrates and recognizes extraordinary achievements in healthcare advertising and marketing.